Fat Perturbations
Relevant Pages
HIV - Modifying Antiretroviral Therapy in Virologically Suppressed HIV-Infected Patients
- Modifying NRTIs in Virologically Suppressed Patients
- Modifying Boosted PI Regimens in Virologically Suppressed Patients
- Lopinavir/Ritonavir Monotherapy
HIV - Key Principles and Recommended Regimens for First-line Antiretroviral Therapy
- Clinical Trials of NNRTI-Based vs PI-Based Therapy
- Clinical Trials Comparing Integrase Inhibitors
- Choosing Among Integrase Inhibitors
HIV - Management of Bone Disease and Body Composition Changes
- Introduction
- Altered Distribution of Body Fat in HIV-Infected Patients
- The Mitochondrial Hypothesis
- Antiretrovirals and Altered Fat Distribution
- Management of Lipoatrophy
- Management of Lipohypertrophy
HIV - Endocrine Disorders: Evaluation and Management
HIV - Special Considerations in the Management of Women With HIV, Including Management of Conception and Pregnancy
Guidelines
- European Guidelines for Treatment of HIV-Infected Adults in Europe—Part III Guidelines for the Prevention and Management of Comorbidities in HIV-Positive Persons
- Management of Metabolic Complications Associated With Antiretroviral Therapy for HIV-1 Infection: Recommendations of an International AIDS Society-USA Panel